Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-066331

Director sold 4,728 shares at $26.93 ($127,325)

  • Director acquired 4,094 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Welgus Howard G. Director 2026-10-15 Option exercise 10b5-1 +822 $6.52 $5,361 36,663 D
Welgus Howard G. Director 2026-10-15 Option exercise 10b5-1 +1,018 $7.51 $7,645 37,681 D
Welgus Howard G. Director 2026-10-15 Option exercise 10b5-1 +2,254 $8.63 $19,452 39,935 D
Welgus Howard G. Director 2026-10-15 Sale 10b5-1 −4,728 $26.93 $127,325 35,207 D
Derivatives
Welgus Howard G. Director 2026-10-15 Option exercise · Stock Option (right to buy) 10b5-1 −822 5,752 D
Welgus Howard G. Director 2026-10-15 Option exercise · Stock Option (right to buy) 10b5-1 −1,018 7,126 D
Welgus Howard G. Director 2026-10-15 Option exercise · Stock Option (right to buy) 10b5-1 −2,254 15,778 D
Open-market sales · 4,728 sh · avg $26.93 · $127,325
Loading xslF345X06/wk-form4_1792442988.xml…